Display options
Cite
Grosse SD, Farnaes L. Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?. Genet Med. 2018;21(2):269-271doi: 10.1038/s41436-018-0124-3.
Grosse, S. D., & Farnaes, L. (2019). Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?. Genetics in medicine : official journal of the American College of Medical Genetics, 21(2), 269-271. https://doi.org/10.1038/s41436-018-0124-3
Grosse, Scott D, and Farnaes, Lauge. "Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?." Genetics in medicine : official journal of the American College of Medical Genetics vol. 21,2 (2019): 269-271. doi: https://doi.org/10.1038/s41436-018-0124-3
Grosse SD, Farnaes L. Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?. Genet Med. 2019 Feb;21(2):269-271. doi: 10.1038/s41436-018-0124-3. Epub 2018 Aug 13. PMID: 30100610; PMCID: PMC6691721.
Copy Download .nbib Format: NLM
Share it on

Genet Med. 2019 Feb;21(2):269-271. doi: 10.1038/s41436-018-0124-3. Epub 2018 Aug 13.

Genomic sequencing in acutely ill infants: what will it take to demonstrate clinical value?.

Genetics in medicine : official journal of the American College of Medical Genetics

Scott D Grosse, Lauge Farnaes

Affiliations

  1. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. [email protected].
  2. Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
  3. Department of Pediatrics, University of California at San Diego, San Diego, California, USA.

PMID: 30100610 PMCID: PMC6691721 DOI: 10.1038/s41436-018-0124-3

[No abstract available.]

References

  1. Kingsmore SF, Petrikin J, Willig LK, et al. Emergency medical genomes: a breakthrough application of precision medicine. Genome Med. 2015;7:82. - PubMed
  2. Friedman JM, Bombard Y, Cornel MC, et al. Genome-wide sequencing in acutely-ill infants: genomic medicine’s critical application? Genet Med. 12 June 2018. https://doi.org/10.1038/s41436-018-0055-z - PubMed
  3. Tilford JM, Payakachat N. Progress in measuring family spillover effects for economic evaluations. Expert Rev Pharmacoecon Outcomes Res. 2015;15:195–198. - PubMed
  4. Bunnik EM, Janssens AC, Schermer MH. Personal utility in genomic testing: is there such a thing? J Med Ethics. 2015;41:322–326. - PubMed
  5. Kohler JN, Turbitt E, Lewis KL, et al. Defining personal utility in genomics: a Delphi study. Clin Genet. 2017;92:290–297. - PubMed
  6. Stark Z, Lunke S, Brett GR, et al. Meeting the challenges of implementing rapid genomic testing in acute pediatric care. Genet Med. 15 May 2018. https://doi.org/10.1038/gim.2018.37 - PubMed
  7. Farnaes L, Hildreth A, Sweeney NM, et al. Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization. NPJ Genom Med. 2018;3:10. - PubMed
  8. Sweeney NM, Nahas SA, Chowdhury S, et al. The case for early use of rapid whole genome sequencing in management of critically ill infants: late diagnosis of Coffin-Siris syndrome in an infant with left congenital diaphragmatic hernia, congenital heart disease and recurrent infections. Cold Spring Harb Mol Case Stud. 2018;4:a002469. - PubMed
  9. Berg JS, Agrawal PB, Bailey DB Jr., et al. Newborn sequencing in genomic medicine and public health. Pediatrics. 2017;139:e20162252. - PubMed
  10. Petrikin JE, Cakici JA, Clark MM, et al. The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. NPJ Genom Med. 2018;3:6. - PubMed
  11. Agarwala V, Khozin S, Singal G, et al. Real-world evidence in support of precision medicine: clinico-genomic cancer data as a case study. Health Aff (Millwood). 2018;37:765–772. - PubMed

MeSH terms

Publication Types

Grant support